YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
The Yes‐associated protein (YAP)/Hippo pathway has been implicated in tissue development, regeneration, and tumorigenesis. However, its role in cholangiocarcinoma (CC) is not established. We show that YAP activation is a common feature in CC patient biopsies and human CC cell lines. Using microarray...
Uloženo v:
| Vydáno v: | Hepatology (Baltimore, Md.) Ročník 62; číslo 5; s. 1497 - 1510 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Wolters Kluwer Health, Inc
01.11.2015
|
| Témata: | |
| ISSN: | 0270-9139, 1527-3350, 1527-3350 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | The Yes‐associated protein (YAP)/Hippo pathway has been implicated in tissue development, regeneration, and tumorigenesis. However, its role in cholangiocarcinoma (CC) is not established. We show that YAP activation is a common feature in CC patient biopsies and human CC cell lines. Using microarray expression profiling of CC cells with overexpressed or down‐regulated YAP, we show that YAP regulates genes involved in proliferation, apoptosis, and angiogenesis. YAP activity promotes CC growth in vitro and in vivo by functionally interacting with TEAD transcription factors (TEADs). YAP activity together with TEADs prevents apoptosis induced by cytotoxic drugs, whereas YAP knockdown sensitizes CC cells to drug‐induced apoptosis. We further show that the proangiogenic microfibrillar‐associated protein 5 (MFAP5) is a direct transcriptional target of YAP/TEAD in CC cells and that secreted MFAP5 promotes tube formation of human microvascular endothelial cells. High YAP activity in human CC xenografts and clinical samples correlates with increased MFAP5 expression and CD31+ vasculature. Conclusions: These findings establish YAP as a key regulator of proliferation and antiapoptotic mechanisms in CC and provide first evidence that YAP promotes angiogenesis by regulating the expression of secreted proangiogenic proteins. (Hepatology 2015;62:1497–1510) |
|---|---|
| Bibliografie: | Supported by ONCOSUISSE grant KLS‐2867‐08‐2011 (to L.M.T.) and Swiss National Science Foundation grant 310030B_147089/1 and European Research Commission Synergy grant 609883 (MERiC) (to M.H.H.). Potential conflict of interest: Patricia Marti, Claudia Stein, Yann Abraham, Monika Pikiolek, Vanessa Orsini, Giorgia Jurisic, Philippe Megel, Claudia Agarinis, Tewis Bouwmeester, Heinz Ruffner, Andreas Bauer, Christian N. Parker, Tobias Schmelzle and Jan S. Tchorz are employed by and/or own stock in Novartis. All microarray data were uploaded to the Gene Expression Omnibus repository (GSE61767, GSE69655). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 0270-9139 1527-3350 1527-3350 |
| DOI: | 10.1002/hep.27992 |